CTRI/2016/03/006778已完成未知
Study of saroglitazar in treatment of prediabetes with dyslipidemia - STOP-D
Deogiri Diabetes Centre0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Willing to participate in the study and follow protocol.
- •Patients of either sex with age group of 20-60 years.
- •Prediabetic patients with HbA1c 5.7- 6.5 % and deranged lipids as per NCEP guidelines.
排除标准
- •Type 1 diabetes mellitus
- •Type 2 diabetes
- •Secondary hypertension.
- •Bronchial asthma.
- •Chronic obstructive pulmonary disease.
- •Any other respiratory disorders.
- •g.Any Hepatic or renal diseases.
- •h.Any other cardiovascular disorder.
- •ï??Pregnant and lactating women.
- •ï??History of known allergy to drugs.
- •ï??Patient concurrently taking other medication which is known to affect the blood sugar and lipid parameters.
- •ï??Smoker, alcoholic and tobacco chewer.
研究者
相似试验
招募中
不适用
Effect Of saroglitazar in patients with type 2 diabetes mellitusCTRI/2017/10/010306Department of Endocrinology
已完成
4 期
Use of Empagliflozin to Treat PrediabetesPrediabetic StateOverweight and ObesityPreDiabetesNCT05426525Oregon State University60
尚未招募
Unknown
Evaluation of Unani drugs in the management of PrediabetesCTRI/2023/09/057645Aligarh Muslim University
进行中（未招募）
1 期
The Rimonabant in treatment of Prediabetes Study: a randomised clinical trial of Rimonabant in the treatment of patients with Prediabetes - Rimonabant StudyImpaired Glucose tolerance and Impaired fasting Glycaemia (Together known as Prediabetes)MedDRA version: 9.1 Level: LLT Classification code 10000146 Term: Abnormal glucose tolerance test (excl DM)MedDRA version: 9.1 Level: LLT Classification code 10056997 Term: Impaired fasting glucoseEUCTR2007-000940-28-GBniversity Hospitals of Leicester NHS Trust300
已完成
不适用
iraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial in JapaACS patient with type II diabetesJPRN-UMIN000006817Department of Cardiovascular Medicine, Saga University20